Frederick R Taylor - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Frederick R Taylor

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

International Immunology|October 7, 2004

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeJanine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.

The Journal of Pain|November 28, 2012

Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley ratsLisa C Loram, Frederick R Taylor, Keith A Strand, et al.

The Journal of Clinical Investigation|February 18, 2003

Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathyNigel A Calcutt, Karen L Allendoerfer, Andrew P Mizisin, et al.

Journal of Neuroimmunology|September 13, 2011

Prior laparotomy or corticosterone potentiates lipopolysaccharide-induced fever and sickness behaviorsLeah E Hains, Lisa C Loram, Frederick R Taylor, et al.

Arthritis Research & Therapy|September 4, 2015

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo studyAnthony Shock, Linda Burkly, Ian Wakefield, et al.

Pageof 6

Search research articles

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

International Immunology|October 7, 2004

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeJanine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.

The Journal of Pain|November 28, 2012

Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley ratsLisa C Loram, Frederick R Taylor, Keith A Strand, et al.

The Journal of Clinical Investigation|February 18, 2003

Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathyNigel A Calcutt, Karen L Allendoerfer, Andrew P Mizisin, et al.

Journal of Neuroimmunology|September 13, 2011

Prior laparotomy or corticosterone potentiates lipopolysaccharide-induced fever and sickness behaviorsLeah E Hains, Lisa C Loram, Frederick R Taylor, et al.

Arthritis Research & Therapy|September 4, 2015

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo studyAnthony Shock, Linda Burkly, Ian Wakefield, et al.

Pageof 6